Literature DB >> 25023052

Ubiquitination involved enzymes and cancer.

Mei-juan Zhou1, Fang-zhi Chen, Han-chun Chen.   

Abstract

Ubiquitination is a post-translational modification process that regulates multiple cell functions. It also plays important roles in the development of cancer. Mechanistically, ubiquitination is a complex process that is comprised of a series of events involving ubiquitin-activating enzymes, ubiquitin-conjugating enzymes and ubiquitin ligases. In general, covalent attachment of ubiquitin to the target proteins marks them for degradation. Dysregulation of the ubiquitination process may cause carcinogenesis. In this review, we summarize recent developments in understanding the relationship between ubiquitination enzymes and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25023052     DOI: 10.1007/s12032-014-0093-6

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  99 in total

1.  Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.

Authors:  S Fang; J P Jensen; R L Ludwig; K H Vousden; A M Weissman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 2.  SCF and Cullin/Ring H2-based ubiquitin ligases.

Authors:  R J Deshaies
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

Review 3.  Back to the future with ubiquitin.

Authors:  Cecile M Pickart
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 4.  Regulation of Skp2 expression and activity and its role in cancer progression.

Authors:  Chia-Hsin Chan; Szu-Wei Lee; Jing Wang; Hui-Kuan Lin
Journal:  ScientificWorldJournal       Date:  2010-06-01

5.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

Review 6.  Role of VHL gene mutation in human renal cell carcinoma.

Authors:  Wani Arjumand; Sarwat Sultana
Journal:  Tumour Biol       Date:  2011-11-29

7.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

Review 8.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

Review 10.  Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.

Authors:  Yi Sun; Hua Li
Journal:  Protein Cell       Date:  2012-11-08       Impact factor: 14.870

View more
  27 in total

Review 1.  Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.

Authors:  Haiqi Lu; Guangliang Li; Chenyi Zhou; Wei Jin; Xiaoling Qian; Zhuo Wang; Hongming Pan; Hongchuan Jin; Xian Wang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma.

Authors:  Junling Zhuang; Fazal Shirazi; Ram Kumar Singh; Isere Kuiatse; Hua Wang; Hans C Lee; Zuzana Berkova; Allison Berger; Marc Hyer; Nibedita Chattopadhyay; Sakeena Syed; Judy Qiuju Shi; Jie Yu; Vaishali Shinde; Stephen Tirrell; Richard Julian Jones; Zhiqiang Wang; R Eric Davis; Robert Z Orlowski
Journal:  Blood       Date:  2019-02-08       Impact factor: 22.113

3.  WP1130 increases cisplatin sensitivity through inhibition of usp9x in estrogen receptor-negative breast cancer cells.

Authors:  Peifen Fu; Feiya Du; Yu Liu; Minya Yao; Shufeng Zhang; Xiaoxiao Zheng; Shusen Zheng
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

4.  The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.

Authors:  Huan-Tian Zhang; Ling-Fei Zeng; Qing-Yu He; W Andy Tao; Zhen-Gang Zha; Chang-Deng Hu
Journal:  Biochim Biophys Acta       Date:  2015-12-02

5.  UBE2S is associated with malignant characteristics of breast cancer cells.

Authors:  Akter Khondker Ayesha; Toshinori Hyodo; Eri Asano; Naoki Sato; Mohammed A Mansour; Satoko Ito; Michinari Hamaguchi; Takeshi Senga
Journal:  Tumour Biol       Date:  2015-08-06

Review 6.  The role of deubiquitinating enzymes in cancer drug resistance.

Authors:  Parthasaradhireddy Tanguturi; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cancer Chemother Pharmacol       Date:  2020-03-07       Impact factor: 3.333

7.  WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression.

Authors:  Man Wu; Xueqing Xia; Jiemiao Hu; Natalie Wall Fowlkes; Shulin Li
Journal:  Nat Commun       Date:  2021-06-09       Impact factor: 14.919

Review 8.  Ubiquitination Regulators Discovered by Virtual Screening for the Treatment of Cancer.

Authors:  Ying-Qi Song; Chun Wu; Ke-Jia Wu; Quan-Bin Han; Xiang-Min Miao; Dik-Lung Ma; Chung-Hang Leung
Journal:  Front Cell Dev Biol       Date:  2021-05-12

Review 9.  Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.

Authors:  Zhenbang Chen; Wenfu Lu
Journal:  Int J Mol Sci       Date:  2015-02-27       Impact factor: 5.923

10.  Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.

Authors:  Eric J Devor; Brandon M Schickling; Henry D Reyes; Akshaya Warrier; Brittany Lindsay; Michael J Goodheart; Donna A Santillan; Kimberly K Leslie
Journal:  Oncol Rep       Date:  2016-02-01       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.